Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.438
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
0.29
Today|||52-Week Range
1.16
-31.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues1.1M6.3M13.2M22.0M
 
 
 
 
 
Cost of Goods Sold332.8K1.6M1.7M2.2M
 
 
 
 
 
Depreciation And Amortization404.2K500.2K571.4K501.4K
 
 
 
 
 
 
Operating ExpensesGross Income393.6K4.2M11.0M19.3M
 
 
 
 
 
General Expenses38.8M31.2M28.3M21.5M
 
 
 
 
 
Research And Development23.7M16.8M12.8M8.9M
 
 
 
 
 
Total Operating Expenses39.6M33.3M30.5M24.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-38.4M-27.0M-17.3M-2.2M
 
 
 
 
 
Extraordinary Credit0.000.000.002.9M
 
 
Extraordinary Charge-1.5M-4.6M-4.4M0.00
 
 
 
 
Pre-Tax Equity Earnings0.00-523.8K-305.3K-15.2K
 
 
 
 
Interest Expense On Debt2.8M3.7M6.9M14.9M
 
 
 
 
 
Other Expenses-16.9K72.7K26.8K-67.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-42.7M-35.7M-28.8M-14.3M
 
 
 
 
 
Income Taxes0.000.00-436.1K0.00
 
 
Minority Interest0.000.00-855.00-648.00
 
 
 
Preferred Dividend0.000.00-46.0K0.00
 
 
Discontinued Operations0.000.00758.6K0.00
 
 
Net Income-42.7M-35.7M-27.6M-14.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS121.8M148.7M151.2M155.4M
 
 
 
 
 
Shares To Calculate EPS Diluted121.8M148.7M151.2M155.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.35-$0.24-$0.18-$0.09
 
 
 
 
 
EPS Diluted-$0.35-$0.24-$0.18-$0.09